NCT00000298View on ClinicalTrials.gov

Buprenorphine Combination Tablet Feasibility - 1

PHASE2CompletedINTERVENTIONAL

0

Timeline

Start Date

August 31, 1995

Conditions

Opioid-Related Disorders

Interventions

DRUG

Buprenorphine/naloxone

Trial Locations (1)

90025

Friends Research Institute, Los Angeles

All Listed Sponsors

lead

National Institute on Drug Abuse (NIDA)

NIH